KYPROLIS 60mg - Carfilzomib by Amgen

    KYPROLIS

    60mg
    Oncology Medications

    KYPROLIS60mg

    KYPROLIS (Carfilzomib) 60mg is a second-generation irreversible proteasome inhibitor for relapsed or refractory multiple myeloma.

    Generic Name:Carfilzomib
    Manufacturer:Amgen

    Key Benefits

    • Nearly doubled PFS vs Velcade in ENDEAVOR (18.7 vs 9.4 months)
    • Superior OS: 47.6 vs 40.0 months
    • Dramatically lower neuropathy (6% vs 32%)
    • KRd regimen: 87-97% ORR — NCCN Category 1
    • Once-weekly option (ARROW trial)

    Contact Us for Pricing

    Get a written quote against a prescription within 24 hours for KYPROLIS 60mg. Our team is available 24/7.

    Direct line: +44 7429 917553

    Prescription required

    We do not proceed without one

    Licensed Türkiye channels

    İTS serial-traceable by karekod

    Delivered in person

    Not shipped by courier

    Written reply

    Quote within 24 hours

    How KYPROLIS Works

    1

    Carfilzomib irreversibly binds to the 20S proteasome chymotrypsin-like activity (β5 subunit), blocking ubiquitin-mediated protein degradation. This causes accumulation of misfolded/damaged proteins, triggering ER stress, unfolded protein response, and ultimately apoptosis in myeloma cells.

    About KYPROLIS 60mg

    KYPROLIS (Carfilzomib) 60mg by Amgen is a breakthrough second-generation proteasome inhibitor that irreversibly binds to the 20S proteasome. The landmark ENDEAVOR trial demonstrated Kyprolis+Dex nearly doubled PFS vs Velcade+Dex (18.7 vs 9.4 months, HR=0.53) with superior OS (47.6 vs 40.0 months) and dramatically lower peripheral neuropathy (6% vs 32%). The KRd regimen (Kyprolis+Revlimid+dexamethasone) achieves 87-97% ORR and is an NCCN Category 1 preferred regimen. Working through licensed Turkish pharmacy channels, we provide authentic Amgen KYPROLIS with complete cold chain handling and a written quote against a prescription, usually within 24 hours.

    Common Uses

    • Relapsed or refractory multiple myeloma
    • KRd regimen (with Lenalidomide + Dexamethasone)
    • Kd regimen (with Dexamethasone alone)
    • Frontline multiple myeloma (transplant-eligible, KRd)

    Dosage Information

    KRd: Cycle 1 Days 1,2: 20mg/m² IV, then 27mg/m² Days 8,9,15,16. Cycle 2+: 27mg/m² Days 1,2,8,9,15,16 of 28-day cycle. Kd (ENDEAVOR): 56mg/m². Hydration required. Infuse over 10-30 min.

    Always consult with a qualified healthcare professional for proper dosing. This information is for reference only.

    Storage & Handling

    Store at 2-8°C. Do not freeze. Reconstitute with 29mL SWFI (60mg vial). After reconstitution: stable 24h at 2-8°C or 4h at room temperature.

    We ensure proper cold chain handling during shipping to maintain product integrity.

    Full prescribing monograph

    A single reference page compiled from the manufacturer's prescribing information and the regulator's public product data. No pricing is published on it.

    Frequently Asked Questions About KYPROLIS

    Find answers to common questions about ordering, pricing, and shipping.

    Ready to Order KYPROLIS?

    Contact our team via WhatsApp for instant quotes, availability, and shipping information.

    Related Oncology Medications Products

    Explore more oncology medications medications from our catalog

    ABRAXANE 100mg - Paclitaxel
    Oncology Medications

    ABRAXANE100mg

    Paclitaxel

    Bristol Myers
    AFINITOR 10mg - Everolimus
    Oncology Medications

    AFINITOR10mg

    Everolimus

    Novartis
    ALECENSA  - Alectinib
    Oncology Medications

    ALECENSA

    Alectinib

    Roche
    ALTUZAN 400mg - Bevacizumab
    Oncology Medications

    ALTUZAN400mg

    Bevacizumab

    Roche